Background: The combination of indomethacin, prochlorperazine and caffeine (IPC) is one of the most utilized formulations for the treatment of migraine attacks in Italy. Several patients suffering from chronic headache overuse this symptomatic medication in the attempt to control their headache. Objective: To verify whether overuse of IPC combination by chronic headache patients is associated with modified disposition of its components. Methods: We studied indomethacin, prochlorperazine, and caffeine disposition in 34 female subjects suffering from primary headaches, subdivided into four groups: eight migraine patients occasionally using IPC combination suppositories-group 1; nine patients with chronic headache and probable medication-overuse headache, daily taking one or more suppositories of the IPC combination-group 2; 11 migraine patients occasionally using mild suppositories of the IPC combination-group 3; six migraine patients occasionally taking tablets of the IPC combination-group 4. The IPC combination habitually used was administered to each patient. Blood samples were taken at baseline and at fixed intervals up to 6 h after administration. Plasma levels of indomethacin and prochlorperazine were assayed by high-pressure liquid chromatographic (HPLC) method; caffeine levels were assayed by enzyme multiplied immunoassay test (EMIT). Pharmacokinetic parameters were calculated by means of a computer software (P K Solutions 2.0. Summit Research Services, Montrose, CO, USA). Results: Half-life of indomethacin was longer, and clearance lower, in group 2 than in the other groups; AUC of indomethacin in group 2 was twice that in group 1 (P < 0.05, Newman-Keuls´ test). Peak concentrations and AUC(0 ->infinity) of caffeine were significantly higher in group 2 than in the other groups (P < 0.05, Newman-Keuls´ test). We could not define prochlorperazine disposition because it was not detectable in the majority of blood samples. Conclusion: Overuse of IPC combination in chronic headache patients is associated with increased plasma levels of indomethacin and caffeine, and with delayed elimination of indomethacin; the high and sustained concentrations of these drugs may cause rebound headache, organ damages, and perpetuate medication-overuse headache.
Attenzione! Scheda prodotto non ancora validata dall'Ateneo
Dati e metadati della pubblicazione sono in fase di verifica da parte dell'Ateneo. In caso di errori o violazione dei diritti d'autore, contattare: firstname.lastname@example.org
|Anno di pubblicazione:||2006|
|Titolo:||Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients|
|Autori:||A. Ferrari; G. Savino; D. Gallesi; D. Pinetti; A. Bertolini; G. Sances; CPR Coccia; G. Pasciullo; S. Leone; M. Loi; E. Sterneri|
|Autori interni:||FERRARI, Anna |
|Digital Object Identifier (DOI):||10.1016/j.phrs.2006.03.022|
|Appare nelle tipologie:||Articolo su rivista|
File in questo prodotto:
|Effect of overuse of the antimigraine combination of indomethacin,.pdf||154.3 kB||Adobe PDF||Post-print||NON PUBBLICO - Accesso privato/ristretto||Administrator Richiedi una copia|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris